There is overlapping evidence that the use of psychedelic drugs creates wild and unusual experiences, reportedly healing depressed people back to normality. This has encouraged a group of scientists to embark on studies in an attempt to disburse psychedelic drugs on the market for treating depression.
This podcast explores the use of medical grade MDMA and psilocybin in healing deep trauma, as well as the benefits of microdosing. The field of psychedelic medicine is emerging as a potential treatment for trauma and anxiety.
New data shows that psychedelics can have immense positive impact when used by someone who knows how to utilize them in the right set and setting, and this meshes with the data from the 60s and 70s that showed their effectiveness. The data coming from labs and academic centers is powerfully positive, particularly for psilocybin and LSD.
The speaker recounts their personal experiences with psychedelics, noting that they didn't make a significant impression. However, they acknowledge that with optimized settings and proper support, these experiences can be very meaningful.
This podcast episode provides a brief but informative overview of psychedelics, including the different types and how they differ from one another, such as in their pharmacological pathways and subjective effects. The safety of some of the more commonly discussed psychedelics is also touched upon.
Studies have shown that classic psychedelics like psilocybin, LSD, mescaline, and DMT do not have an addictive signal in all animal models tested, and may even offer some therapeutic benefits for depression.